Read more

August 03, 2024
2 min read
Save

ASTRO members receive fellows designation

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

American Society for Radiation Oncology selected 48 members to receive ASTRO fellow designation.

The honorees will be recognized Oct. 1 during a ceremony at ASTRO Annual Meeting in Washington, D.C.

Quote from Jeff M. Michalski, MD, MBA, FASTRO

ASTRO fellow designation honors individuals who made significant contributions to the society and radiation oncology through research, patient care, education or service to the field. Only 498 of ASTRO’s 10,000-plus members around the world have received FASTRO designation since 2006.

“On behalf of ASTRO, I commend these outstanding physicians, physicists and scientists for their far-reaching contributions to radiation oncology, including their leadership in advancing cancer research, education and clinical care to improve patient outcomes,” Jeff M. Michalski, MD, MBA, FASTRO, chair of the ASTRO Board of Directors, said in a press release.

The 2024 fellows are:

  • Carryn Anderson, MD, University of Iowa
  • Janna Z. Andrews, MD, Northwell Health
  • Leslie Ballas, MD, Cedars-Sinai
  • Beth Beadle, MD, PhD, Stanford University
  • Andrea Bezjak, MD, Princess Margaret Cancer Centre
  • Rachel C. Blitzblau, MD, PhD, Duke University
  • Aileen Chen, MD, The University of Texas MD Anderson Cancer Center
  • Junzo P. Chino, MD, Duke University
  • Casey Chollet-Lipscomb, MD, Tennessee Oncology
  • Christine S. Chung, MD, John Muir Cancer Medical Group
  • Curtiland Deville, MD, Johns Hopkins University
  • Kiran Devisetty, MD, Johnson & Johnson
  • Felix Y. Feng, MD, University of California, San Francisco
  • Mary Feng, MD, University of California, San Francisco
  • Laura M. Freedman, MD, University of Miami
  • Thomas J. Galloway, MD, Fox Chase Cancer Center
  • Sharad Goyal, MD, George Washington University
  • Michael G. Haddock, MD, Mayo Clinic
  • Jona A. Hattangadi-Gluth, MD, University of California, San Diego
  • Daniel J. Indelicato, MD, University of Florida
  • Jerry Jaboin, MD, PhD, MBA, University of Oklahoma
  • Corbin R. Johnson, MD, Vanderbilt University
  • Nagendra (Bobby) S. Koneru, MD, Paramount Oncology Group
  • Yaacov Lawrence, MD, Sheba Medical Center
  • Lilie Lin, MD, The University of Texas MD Anderson Cancer Center
  • Shannon M. MacDonald, MD, Massachusetts General Hospital
  • Brian Marples, PhD, University of Rochester
  • Jyoti S. Mayadev, MD, University of California, San Diego
  • Dimitris N. Mihailidis, PhD, University of Pennsylvania
  • Jean M. Moran, PhD, Memorial Sloan Kettering Cancer Center
  • Quynh-Nhu Nguyen, MD, The University of Texas MD Anderson Cancer Center
  • Lincoln Pao, MD, Colorado Urology Associates
  • Tony S. Quang, MD, JD, VA Long Beach Medical Center
  • Amar Rewari, MD, MBA, Luminis Health
  • Kenneth B. Roberts, MD, Yale University
  • Clifford G. Robinson, MD, Washington University in St. Louis
  • Julie K. Schwarz, MD, PhD, Washington University in St. Louis
  • David Sher, MD, MPH, University of Texas Southwestern
  • Malika Siker, MD, Medical College of Wisconsin
  • Oscar Streeter, MD, Summa Health Medical Group
  • Cristiane Takita, MD, MBA, University of Miami
  • Stephanie Terezakis, MD, University of Minnesota
  • Mylin A. Torres, MD, Emory University
  • Christina Tsien, MD, McGill University
  • James S. Welsh, MD, Loyola University
  • Ying Xiao, PhD, University of Pennsylvania
  • Kamil M. Yenice, PhD, The University of Chicago
  • Hsiang-Hsuan Michael Yu, MD, Moffitt Cancer Center